Utah Retirement Systems Horizon Therapeutics Public LTD CO Transaction History

Utah Retirement Systems

$8.44 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $19,796 - $23,148	200 Added 0.52%	38,500 $4.45 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $105,974 - $123,618	-1,100 Reduced 2.79%	38,300 $3.94 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $10,732 - $11,350	100 Added 0.25%	39,400 $4.3 Million
Q4 2022 Feb 15, 2023	SELL	$62.39 - $113.8 $56,151 - $102,420	-900 Reduced 2.24%	39,300 $4.47 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $11,784 - $16,934	200 Added 0.5%	40,200 $2.49 Million

Q2 2022 Aug 16, 2022	BUY	$79.4 - $116.36 $87,340 - $127,996	1,100 Added 2.83%	40,000 $3.19 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $60,494 - $76,867	-700 Reduced 1.77%	38,900 $4.09 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $9,856 - $11,991	100 Added 0.25%	39,600 $4.27 Million
Q3 2021 Nov 16, 2021	SELL	$91.91 - $110.37 $193,011 - $231,777	-2,100 Reduced 5.05%	39,500 $4.33 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $353,584 - $393,272	4,100 Added 10.93%	41,600 $3.9 Million
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $122,111 - $162,316	-1,700 Reduced 4.34%	37,500 $3.45 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $113,900 - $143,463	1,700 Added 4.53%	39,200 $2.87 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $1.65 Million - $2.38 Million	29,800 Added 387.01%	37,500 $2.91 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $3,020 - $5,698	-100 Reduced 1.28%	7,700 $428,000
Q4 2019 Feb 12, 2020	BUY	$25.43 - $36.67 $2,543 - $3,667	100 Added 1.3%	7,800 $282,000
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $177,100 - $215,369	7,700 New	7,700 $210,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account